Simple bedside test may help ICU doctors safely reduce blood pressure drugs
NCT ID NCT03455738
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a non-invasive monitoring tool (called dynamic arterial elastance, or Eadyn) can predict how a patient's blood pressure will respond when doctors reduce the dose of norepinephrine, a drug used to raise blood pressure. The study included 35 ICU patients with vasoplegia (a condition of very low blood pressure). Researchers measured Eadyn before and after lowering the norepinephrine dose. The goal was to see if Eadyn could identify which patients would have a significant drop in blood pressure, helping doctors make safer decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors safely reduce norepinephrine in ICU patients, potentially shortening treatment and avoiding unnecessary medication.
- What could go wrong
- This is a small, early study (35 patients) testing a monitoring method, not a treatment. The measure may be less accurate in patients on norepinephrine, and results may not apply to all ICU settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASOPLEGIA SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens-Picardie
Amiens, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.